Study | Follow-Up | Adverse Clinical Outcomes | Reference |
---|---|---|---|
Bordignon 2019 | 4.6 mos | 1 major bleeding | [12] |
Jin 2022 | 12.8 mos | 1 DRT, 3 PDL | [13] |
Marroquin 2022 | 18 mos | 1PDL, 1 major bleeding | [19] |
Beneduce 2019 | 1 mo | N/A | [20] |
Lange 2016 | 1.5 mos | N/A | [21] |
Saccà 2017 | until discharge | N/A | [22] |
Jalal 2016 | 8.6 ± 2 mos | 1PDL | [23] |
Lee 2018 | 27.1 ± 20.3 mos | 1 stroke, 1 DRT, 2 PDL | [24] |
Popescu 2022 | 3 mos | N/A | [25] |
Tan 2021 | 3.75 mos | 1 major bleeding | [26] |
Tsai 2023 | 20.4 mos | N/A | [27] |
Bellmann 2017 | 3 mos | N/A | [28] |
Aytemir 2016 | 48Â h | N/A | [29] |
Dugo 2016 | 1.5 mos | N/A | [30] |
Lee 2017 | 4 d | N/A | [31] |
De Roeck 2019 | 9 mos | N/A | [32] |
Chang 2023 | 5 mos | N/A | [33] |
Mohandes 2020 | until discharge | N/A | [34] |
Kaczmarek 2021 | 10 mos | 1 DRT, 1 PDL, 1 death | [35] |
Marcon 2023 | 6 mos | N/A | [36] |
Cruz-Gonzalez 2017 | until discharge | N/A | [37] |
Cammalleri 2016 | until discharge | N/A | [38] |
Pak 2013 | 1.5 mos | N/A | [39] |
Yadav 2017 | 1.5 mos | N/A | [40] |
Martins 2018 | 1 mo | N/A | [41] |
Del Furia 2017 | until discharge | N/A | [42] |